NCT03435939View on ClinicalTrials.gov

Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

June 11, 2024

Study Completion Date

April 30, 2025

Conditions
Cystic Fibrosis
Interventions
DRUG

Losartan

50 mg/day for 7 days followed by 100 mg/day for 12 weeks

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER